The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ZVRA FINANCIAL STATEMENTS

Zevra Therapeutics Inc. — balance sheet, income statement and cash flow trends

ZVRAZevra Therapeutics Inc.

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M0100 M2020202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue39.7 M $Gross Profit38.1 M $ · 96%Operating Income16.8 M $ · 42%Pre-tax Income12.8 M $ · 32%Net Income to Owners8.8 M $ · 22%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue39.7 M $+44.4%
Gross Profit38.1 M $+55.6%
Operating Income16.8 M $—
EBITDA16.8 M $—
Net Income to Owners8.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M2020202120222023202420252026

Capital Structure

Q2 2026
Total Assets302.7 M
  • Equity217.7 M $72%
  • Current Liabilities48.6 M $16%
  • Long-term Liabilities36.4 M $12%

Key Figures

YoY change
Total Assets302.7 M $+75.7%
Total Liabilities85.1 M $-23.0%
Total Equity217.7 M $+251.8%
Cash & ST Investments221.6 M $+227.1%
Total Debt1.5 M $-96.6%
Net Debt-143.8 M $-20,187.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-50 M02020202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
050 M100 M23.2 M $Operating111.1 M $Investing-51.2 M $Financing83 M $Net Change

Key Figures

YoY change
Operating Cash Flow23.2 M $—
Capital Expenditures252 K $-14.9%
Free Cash Flow22.9 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ZVRA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.